EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Novel drug-like fluorenyl derivatives as selective butyrylcholinesterase and β-amyloid inhibitors for the treatment of Alzheimer’s disease

Anna Pasieka, Dawid Panek, Paula Zaręba, Emilia Sługocka, Natalia Gucwa, Alba Espargaró, Gniewomir Latacz, Nadia Khan, Adam Bucki, Raimon Sabaté, Anna Więckowska, Barbara Malawska

Bioorganic & Medicinal Chemistry · 2023

DOI: 10.1016/j.bmc.2023.117333 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Bioorganic & Medicinal Chemistry, 2023. Verfasst von Anna Pasieka und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Physicochemical Drug Analysis, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna St. 9, 30-688 Kraków, Poland. Hauptthemen laut MEDLINE: Butyrylcholinesterase, Alzheimer Disease. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Narodowym Centrum Nauki, National Science Centre Poland.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Butyrylcholinesterase (BuChE) and amyloid β (Aβ) aggregation remain important biological target and mechanism in the search for effective treatment of Alzheimer's disease. Simultaneous inhibition thereof by the application of multifunctional agents may lead to improvement in terms of symptoms and causes of the disease. Here, we present the rational design, synthesis, biological evaluation and molecular modelling studies of novel series of fluorene-based BuChE and Aβ inhibitors with drug-like characteristics and advantageous Central Nervous System Multiparameter Optimization scores. Among 17 synthesized and tested compounds, we identified 22 as the most potent eqBuChE inhibitor with IC50 of 38 nM and 37.4% of Aβ aggregation inhibition at 10 μM. Based on molecular modelling studies, including molecular dynamics, we determined the binding mode of the compounds within BuChE and explained the differences in the activity of the two enantiomers of compound 22. A novel series of fluorenyl compounds meeting the drug-likeness criteria seems to be a promising starting point for further development as anti-Alzheimer agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ButyrylcholinesteraseAlzheimer DiseaseHumansAmyloid beta-PeptidesCholinesterase InhibitorsStructure-Activity RelationshipMolecular Dynamics SimulationAcetylcholinesteraseDrug DesignMolecular StructureMolecular Docking Simulation

Stichwörter der Autor:innen

AggregationAlzheimer’s diseaseButyrylcholinesterase inhibitorsDrug-likenessFluorene scaffoldβ-amyloid

Substanzen

ButyrylcholinesteraseAmyloid beta-PeptidesCholinesterase InhibitorsAcetylcholinesterase

Autor:innen und Institutionen

  • Department of Physicochemical Drug Analysis, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna St. 9, 30-688 Kraków, Poland.
  • Department of Physicochemical Drug Analysis, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna St. 9, 30-688 Kraków, Poland. Electronic address: dawid.panek@uj.edu.pl.
  • Department of Physicochemical Drug Analysis, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna St. 9, 30-688 Kraków, Poland; Doctoral School of Medical and Health Sciences, Jagiellonian University M…
  • Department of Pharmacy and Pharmaceutical Technology and Physical-Chemistry, School of Pharmacy and Food Sciences, University of Barcelona, Av Joan XXIII 27-31, 08028 Barcelona, Spain; Institute of Nanoscience and Nanot…
  • Department of Technology and Biotechnology of Drugs, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna St. 9, 30-688 Kraków, Poland.
  • Department of Technology and Biotechnology of Drugs, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna St. 9, 30-688 Kraków, Poland; Departement of Pathophysiology, Jagiellonian University Medical C…

Förderung

  • Narodowym Centrum Nauki
  • National Science Centre Poland

Zitieren

APA

Pasieka, A., Panek, D., Zaręba, P., Sługocka, E., Gucwa, N., Espargaró, A., Latacz, G., Khan, N., Bucki, A., Sabaté, R., Więckowska, A., & Malawska, B. (2023). Novel drug-like fluorenyl derivatives as selective butyrylcholinesterase and β-amyloid inhibitors for the treatment of Alzheimer’s disease. Bioorganic & Medicinal Chemistry. https://doi.org/10.1016/j.bmc.2023.117333

Vancouver

Pasieka A, Panek D, Zaręba P, Sługocka E, Gucwa N, Espargaró A, et al. Novel drug-like fluorenyl derivatives as selective butyrylcholinesterase and β-amyloid inhibitors for the treatment of Alzheimer’s disease. Bioorganic & Medicinal Chemistry. 2023. doi:10.1016/j.bmc.2023.117333

BibTeX
@article{Pasieka2023,
  author = {Pasieka, Anna and Panek, Dawid and Zaręba, Paula and Sługocka, Emilia and Gucwa, Natalia and Espargaró, Alba and Latacz, Gniewomir and Khan, Nadia and Bucki, Adam and Sabaté, Raimon and Więckowska, Anna and Malawska, Barbara},
  title = {Novel drug-like fluorenyl derivatives as selective butyrylcholinesterase and β-amyloid inhibitors for the treatment of Alzheimer’s disease},
  journal = {Bioorganic & Medicinal Chemistry},
  year = {2023},
  doi = {10.1016/j.bmc.2023.117333}
}
Kostenlos starten →